These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 1666067)

  • 21. [Preliminary evaluation of methadone program in Kraków].
    Kamenczak A; Chrostek Maj J; Kroch S; Groszek B
    Przegl Lek; 2000; 57(10):525-30. PubMed ID: 11199879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinial study of "qingjunyin" detoxification for the treatment of heroin addicts].
    Lu H; Wang G; Lan S; Yuan D; Zhan C
    Zhong Yao Cai; 1997 Jun; 20(6):319-21. PubMed ID: 12572478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical use of clonidine in outpatient detoxification from opiates.
    Washton AM; Resnick RB
    Prog Clin Biol Res; 1981; 71():277-84. PubMed ID: 7330080
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug czar seeks new emphasis on methadone treatment.
    AIDS Policy Law; 1997 Oct; 12(20):7. PubMed ID: 11364789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public policy statement on Office-Based Opioid Agonist Treatment (OBOT).
    J Addict Dis; 2005; 24(3):153-61. PubMed ID: 16186090
    [No Abstract]   [Full Text] [Related]  

  • 28. Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study.
    Salamina G; Diecidue R; Vigna-Taglianti F; Jarre P; Schifano P; Bargagli AM; Davoli M; Amato L; Perucci CA; Faggiano F;
    Subst Use Misuse; 2010 Oct; 45(12):2076-92. PubMed ID: 20438317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of opiate detoxification in jails.
    Fiscella K; Moore A; Engerman J; Meldrum S
    J Addict Dis; 2005; 24(1):61-71. PubMed ID: 15774411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of quality of life for drug addicts in methadone maintenance treatment clinics, community and compulsory detoxification institutions in Sichuan Province].
    Xiao L; Wu Z; Wang Y; Chen J
    Wei Sheng Yan Jiu; 2009 Jan; 38(1):67-70. PubMed ID: 19267080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Childhood sexual abuse, post-traumatic stress disorder, and use of heroin among female clients in Israeli methadone maintenance treatment programs (MMTPS).
    Schiff M; Levit S; Cohen-Moreno R
    Soc Work Health Care; 2010; 49(9):799-813. PubMed ID: 20938876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Group psychotherapy for opiate addicts in methadone maintenance treatment--a controlled trial.
    Scherbaum N; Kluwig J; Specka M; Krause D; Merget B; Finkbeiner T; Gastpar M
    Eur Addict Res; 2005; 11(4):163-71. PubMed ID: 16110222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients.
    Backmund M; Meyer K; Eichenlaub D; Schütz CG
    Drug Alcohol Depend; 2001 Oct; 64(2):173-80. PubMed ID: 11543987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonidine for opiate detoxification: outpatient clinical trials.
    Washton AM; Resnick RB
    Am J Psychiatry; 1980 Sep; 137(9):1121-2. PubMed ID: 7425173
    [No Abstract]   [Full Text] [Related]  

  • 35. Craving and drug reward: a comparison of methadone and clonidine in detoxifying opiate addicts.
    Dawe S; Gray JA
    Drug Alcohol Depend; 1995 Oct; 39(3):207-12. PubMed ID: 8556969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Health status of methadone recipients before entering a methadone program].
    Tschan F; Tueller N
    Schweiz Med Wochenschr; 1992 Nov; 122(46):1758-69. PubMed ID: 1448681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Client and counselor attitudes toward the use of medications for treatment of opioid dependence.
    Rieckmann T; Daley M; Fuller BE; Thomas CP; McCarty D
    J Subst Abuse Treat; 2007 Mar; 32(2):207-15. PubMed ID: 17306729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cocaine abuse among heroin addicts in Spain.
    Torrens M; San L; Peri JM; Olle JM
    Drug Alcohol Depend; 1991 Jan; 27(1):29-34. PubMed ID: 2029857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Frequency and causes of premature termination (drop-out) during in-patient opiate detoxification].
    Gössling HW; Gunkel S; Schneider U; Melles W
    Fortschr Neurol Psychiatr; 2001 Oct; 69(10):474-81. PubMed ID: 11602924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can opiate addicts tell us about their relapse risk? Subjective predictors of clinical prognosis.
    Powell J; Dawe S; Richards D; Gossop M; Marks I; Strang J; Gray J
    Addict Behav; 1993; 18(4):473-90. PubMed ID: 8213302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.